Use access key #2 to skip to page content.
$17.97 -0.19 (-1.05%)
11/21/2008 4:00 PM

Alnylam Pharmaceuticals, Inc. (ALNY)

CAPS Rating:
***

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ALNY

Add Stock to Watchlist

What the Community Thinks

Total Members

193 Outperforms
23 Underperforms
 

All-Stars

40 Outperforms
10 Underperforms
 

Wall Street

3 Outperforms
2 Underperforms
 

Members bullish on ALNY are also bullish on:

Members bearish on ALNY are also bearish on:

Ticker Tags

Biotechnology (230), Bio-Pharmaceuticals (26), Small Cap (1354), Rule Breakers Universe (137)
Suggest a tag

Alnylam Pharmaceuticals, Inc. At A Glance

Current Price: $17.97
Last Trade Time: 11/21/2008 4:00 PM
Open: $18.22
Previous Close: $18.16
Daily Range: $16.37 - $18.74
52-Week Range: $17.99 - $36.37
Volume: 866,289
Market Cap: $751.97M
P/E Ratio: 41.01
Compare Our Special Broker Offers!

Stock Trends

ALNY VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ALNY

More Headlines...

Top Bull Pitch

Recs

1

Alnylam Pharmaceuticals, Inc. (ALNY)

Avatar nepedal (54.63) Submitted: 5/11/08 6:11 PM

amazing science. we'll see if they can get it to work, though

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Alnylam Pharmaceuticals, Inc. (ALNY)

Avatar daviddai (50.05) Submitted: 3/08/07 3:06 PM

The company is trading at 18/share. This price is overvalued for a 600M Market Cap company. 1. weak product pipeline. With the exception of 1 product, all other proudcts are at preclinical stage, which means that it'll take at least 3 years for them to take off. There's too much risk with the pr...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 50 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ALNY)

Avatar quinpeung (79.86) Submitted: 11/15/08 3:27 PM : Outperform Start Price: $22.70 ALNY Score: -8.74

This is a CAPS play intended to force me to follow the RNAi industry. Phase II results for ALN-RSV01 were encouraging. Alnylam's pipeline is impressive, although the company website is rather crytpic. Nevertheless, they have demonstrated clinical know-how in the RNAi field and should rake in more up front payments as time progresses.

As a CAPS play, entry point seems good.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ALNY)

Avatar moof77 (46.47) Submitted: 11/12/08 12:35 AM : Outperform Start Price: $26.48 ALNY Score: -18.11

Great tech, great partnerships, plenty of cash on hand for the short term.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ALNY)

Avatar jodamaju (< 20) Submitted: 10/13/08 5:25 PM : Outperform Start Price: $26.00 ALNY Score: -3.31

MAJOR PATENTS IN RNA INTERFERENCE WITH STRONG PARTNERSHIP WITH MULTIPLE MAJOR PHARMACEUTICAL COMPANIES.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ALNY)

Avatar RNZ100 (< 20) Submitted: 10/08/08 8:24 PM : Outperform Start Price: $23.96 ALNY Score: -1.13

Oversold (but then again, what isn't?!)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ALNY)

Avatar nrkrishna (23.57) Submitted: 8/27/08 1:35 PM : Outperform Start Price: $28.87 ALNY Score: 3.29

nice pullback - speculative pick

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 50 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLeerinkSwan 92.44 08/20/08 Underperform NS $31.93-43.72%-40.47%+3.25
TrackNeedham < 20 03/03/08 Underperform NS $26.50-32.19%-43.04%-10.85
TrackCantorFitz < 20 09/11/07 Outperform NS $27.06-33.59%-48.14%+14.55
TrackRodmanRen 51.88 11/03/06 Outperform NS $18.45-2.60%-44.76%+42.15
TrackBofASec 95.85 10/31/06 Outperform NS $20.71-13.23%-45.09%+31.86

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links